Medical ProductsCompany
United Therapeutics M&A Summary
United Therapeutics has acquired 4 companies, including 2 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
United Therapeutics’ largest acquisition to date was in 2018, when it acquired SteadyMed for $216M. It’s largest disclosed sale occurred in 2015, when it sold Rare Pediatric Disease Priority Review Voucher to AbbVie for $350M. United Therapeutics has acquired in 4 different US states. The Company’s most targeted sectors include life science (50%) and medical products (25%).
United Therapeutics Business Overview
Where is United Therapeutics headquartered?
United Therapeutics is headquartered in Silver Spring, Maryland.
What is United Therapeutics’ revenue?
United Therapeutics disclosed revenue of 2,328M USD for 2023 and 1,936M USD for 2022.
How many employees does United Therapeutics have?
United Therapeutics has 950 employees.
What sector is United Therapeutics in?
United Therapeutics is a medical products company.
When was United Therapeutics founded?
United Therapeutics was founded in 1996.
M&A Summary
-
M&A Total Activity5
- M&A Buy Activity4
- M&A Sell Activity1
- Total Sectors Invested 3
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
- M&A Advisors 2